RETRACTED: An open-label trial comparing alendronate and alphacalcidol in reducing falls and hip fractures in disabled stroke patients.
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal).
This article has been retracted at the request of the Editor-in-Chief due to include issues around study governance (ethical oversight and funding), implausible participant recruitment, implausible study conduct and publication timelines, authorship misconduct, conflicting statements about randomization methodology, implausibly similar randomized groups, implausible results, impossible results, duplicate reporting and data errors. In addition, several other publications reporting non-randomized research by members of this group of investigators have been retracted.
Sato
Yoshihiro
Y
Department of Neurology, Mitate Hospital, Tagawa, Japan. Electronic address: y-sato@ktarn.or.jp.
Iwamoto
Jun
J
Institute for Sports Medicine, Keio University School of Medicine, Tokyo, Japan.
Honda
Yoshiaki
Y
Department of Neurology, Mitate Hospital, Tagawa, Japan.
D000058:Accidental Falls / Q000517:prevention & control*; D000368:Aged; D019386:Alendronate / Q000627:therapeutic use*; D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001842:Bone and Bones / Q000378:metabolism / Q000473:pathology; D002117:Calcitriol / Q000097:blood; D006233:Persons with Disabilities / Q000706:statistics & numerical data*; D005260:Female; D006620:Hip Fractures / Q000517:prevention & control*; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D008297:Male; D020521:Stroke / Q000150:complications*
D050071:Bone Density Conservation Agents; D006887:Hydroxycholecalciferols; D002117:Calcitriol; C008088:alfacalcidol; D019386:Alendronate